| API | active pharmaceutical ingredient |
| BCA | bicinchoninic acid assay |
| cATMP | combined advanced therapy medicinal product |
| CHUV | centre hospitalier universitaire vaudois |
| CMV | cytomegalovirus |
| Da | Daltons |
| DMEM | Dulbecco’s modified Eagle medium |
| DMSO | dimethyl sulfoxide |
| EBV | Epstein-Barr virus |
| EDTA | ethylenediaminetetraacetic acid |
| FBS | fetal bovine serum |
| GAG | glycosaminoglycan |
| GMP | good manufacturing practices |
| GO | gene ontology |
| HA | hyaluronic acid |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| HIV | human immunodeficiency virus |
| H2O2 | hydrogen peroxide |
| HSV | herpes simplex virus |
| HTLV | human T-cell lymphotropic virus |
| LVE | linear viscoelastic region |
| MCB | master cell bank |
| MD | medical device |
| MW | molecular weight |
| Pa | Pascals |
| Pa·s | Pascal seconds |
| PBS | phosphate-buffered saline |
| PCB | parental cell bank |
| PDT | population doubling time |
| PDV | population doubling value |
| Ph. Eur. | European pharmacopoeia |
| PRP | platelet-rich plasma |
| QC | quality control |
| ROS | reactive oxygen species |
| TEAC | Trolox equivalent antioxidant capacity |
| TrSt | standardized transplant product |
| USA | United States of America |
| UV | ultraviolet |
| WCB | working cell bank |